SYDNEY, Jan 15 (Reuters) - The following statement was released by Mayne Pharma Ltd. (MYP.AX: Quote, Profile , Research). Mayne Pharma Limited (ASX: MYP) today announced that the proposed consent agreement in relation to the acquisition of Mayne Pharma Limited by a subsidiary of Hospira Inc. is with the Commissioners of the Federal Trade Commission (FTC) for final approval.
